These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22322134)

  • 21. Thrombophilia and adverse pregnancy outcome.
    Brenner B
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):443-56, ix. PubMed ID: 16962920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for placental abruption in a socio-economically disadvantaged region.
    Budde MP; De Lange TE; Dekker GA; Chan A; Nguyen AM
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):687-93. PubMed ID: 17701669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombophilia and adverse pregnancy outcome.
    Brenner B; Aharon A
    Clin Perinatol; 2007 Dec; 34(4):527-41, v. PubMed ID: 18063103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
    Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
    Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The thrombophilic fetus.
    Tranquilli AL; Emanuelli M
    Med Hypotheses; 2006; 67(5):1226-9. PubMed ID: 16814942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science?
    Larciprete G; Rossi F; Deaibess T; Brienza L; Barbati G; Romanini E; Gioia S; Cirese E
    J Obstet Gynaecol Res; 2010 Oct; 36(5):996-1002. PubMed ID: 20868443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia.
    Sikkema JM; Franx A; Bruinse HW; van der Wijk NG; de Valk HW; Nikkels PG
    Placenta; 2002 Apr; 23(4):337-42. PubMed ID: 11969345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gestational vascular complications.
    Younis JS; Samueloff A
    Best Pract Res Clin Haematol; 2003 Jun; 16(2):135-51. PubMed ID: 12763483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Maternal and perinatal prognosis of pregnancy with chronic hypertension and analysis of associated factors].
    Sun Y; Yang YL; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):434-7. PubMed ID: 17961329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction.
    Robinson WP; Peñaherrera MS; Jiang R; Avila L; Sloan J; McFadden DE; Langlois S; von Dadelszen P
    Prenat Diagn; 2010 Jan; 30(1):1-8. PubMed ID: 19918961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombophilia in pregnancy: venous thromboembolism, fetal loss, preeclampsia, intrauterine growth restriction].
    Zotz RB; Sucker C; Gerhardt A
    Hamostaseologie; 2008 Dec; 28(5):455-64. PubMed ID: 19132175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption.
    Ananth CV
    Semin Perinatol; 2014 Apr; 38(3):131-2. PubMed ID: 24836823
    [No Abstract]   [Full Text] [Related]  

  • 38. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors.
    Tranquilli AL; Giannubilo SR; Dell'Uomo B; Grandone E
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):144-7. PubMed ID: 15541848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between maternal thrombophilia and stillbirth according to causes/associated conditions of death.
    Monari F; Alberico S; Avagliano L; Cetin I; Cozzolino S; Gargano G; Marozio L; Mecacci F; Neri I; Tranquilli AL; Venturini P; Facchinetti F
    Early Hum Dev; 2012 Apr; 88(4):251-4. PubMed ID: 21945103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.